Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 5Pancreatic Neoplasms 3Inflammatory Bowel Diseases 3Diverticulitis 3Carcinoma, Hepatocellular 3Stomach Neoplasms 1Psychological Well-Being 1Postoperative Complications 1Motor Activity 1Lung Neoplasms 1Liver Neoplasms 1Hypotension 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colorectal Neoplasms 1Agnosia 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Tea × Gastrointestinal × Clear all
NCT01438476 2020-02-12

Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

M.D. Anderson Cancer Center

Phase 3 Completed
178 enrolled 9 charts
Gastrointestinal

Agnosia, Liver Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡